NCT00216008View on ClinicalTrials.gov

Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.

PHASE2TerminatedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Esophageal AdenocarcinomasAdenocarcinomas of the Gastroesophageal Junction

Interventions

DRUG

docetaxel

DRUG

cisplatin

PROCEDURE

radiation

PROCEDURE

surgery

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Sponsors

Collaborators (1)

Aventis Pharmaceuticals

All Listed Sponsors

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER